Shuanghuanglian eye drops, preparation method thereof, method for improving stability thereof, and method for extracting extract thereof

By controlling and removing the residues of methamidophos and oxylephants in honeysuckle, scutellaria baicalensis and forsythia in Shuanghuanglian eye drops, the quality stability of Shuanghuanglian eye drops is improved and the chlorogenic acid content caused by pesticide residues is solved. Reduce problems and achieve consistency and stability of product quality.

CN115569160BActive Publication Date: 2024-11-26SHENYANG XINGQI PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211229885.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-08
Publication Date
2024-11-26
Estimated Expiration
2042-10-08

AI Technical Summary

Technical Problem

When the existing Shuanghuanglian eye drops are made of honeysuckle medicinal materials with pesticide residues, the chlorogenic acid content decreases, affecting quality stability. The existing technology fails to effectively consider the impact of pesticide residues on quality stability.

Method used

By controlling the content of methylamino and oxylafen in honeysuckle, scutellaria baicalensis and forsythia, the pesticide residues are removed using carbon dioxide supercritical treatment to ensure that the content of methylamino and oxylafen in the extract is not greater than 5μg/kg and 8μg/ kg to improve the quality stability of Shuanghuanglian eye drops.

Benefits of technology

Effectively increase the content of chlorogenic acid in Shuanghuanglian eye drops, avoid the unqualified quality caused by methylaminophosphorus and oxylephants, and ensure that the chlorogenic acid content of different batches of products is basically consistent, improving the quality stability sex.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003881128570000211
    Figure BDA0003881128570000211
  • Figure BDA0003881128570000221
    Figure BDA0003881128570000221
  • Figure BDA0003881128570000241
    Figure BDA0003881128570000241
Patent Text Reader

Abstract

The present invention relates to a method for improving the quality stability of Shuanghuanglian eye drops, and the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria and forsythia. The method comprises the following steps: 1) extracting honeysuckle, scutellaria and forsythia to obtain corresponding medicinal material extracts for preparing Shuanghuanglian eye drops; 2) using the obtained medicinal material extracts to prepare Shuanghuanglian eye drops; wherein the method comprises: - controlling the content of methyl parathion in at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof to be not more than 5 μg / kg, and the content of omethoate to be not more than 8 μg / kg; - extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops. The present invention also relates to a method for extracting an extract for preparing Shuanghuanglian eye drops from medicinal materials, a method for preparing Shuanghuanglian eye drops, and Shuanghuanglian eye drops.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medicine, and in particular to a method for improving the quality stability of Shuanghuanglian eye drops, a method for extracting an extract for preparing Shuanghuanglian eye drops from medicinal materials, a method for preparing Shuanghuanglian eye drops, and Shuanghuanglian eye drops. Background Art

[0002] Shuanghuanglian eye drops have the effects of dispelling wind and clearing heat, detoxifying and removing nebula, and are mainly used to treat herpes simplex caused by wind evil and heat toxins and viral dendritic keratitis. Shuanghuanglian eye drops powder is prepared by extracting and preparing a series of processes including honeysuckle, scutellaria and forsythia in a weight ratio of 1:1:2; at the same time, an eye drop solvent is prepared and packaged into tubes. Before use, the powder is fully dissolved in the eye drop solvent for use.

[0003] Chinese medicinal materials are easily attacked by pests and diseases during the planting process, and the use of pesticides is an effective prevention and control method. The <0212 General Rules for the Verification of Medicinal Materials and Decoction Pieces> of the Chinese Pharmacopoeia (2020 Edition) stipulates 33 banned pesticides, so in principle, the residues of banned pesticides should not appear in honeysuckle, scutellaria and forsythia. However, according to Li Jiaxin et al. "Risk Assessment of Organophosphorus Prohibited and Restricted Pesticides in Honeysuckle", China Journal of Traditional Chinese Medicine, June 2018, Vol. 43, No. 11, some banned pesticides were still found in honeysuckle.

[0004] Furthermore, the inventors have found that when Shuanghuanglian preparations are made from honeysuckle medicinal materials with pesticide residues, the chlorogenic acid content may decrease.

[0005] It is well known in the art that chlorogenic acid is one of the main antibacterial and antiviral effective pharmacological ingredients of honeysuckle, and it plays an important role in the therapeutic effect of Shuanghuanglian eye drops. Structurally, chlorogenic acid is an ester formed by caffeic acid and quinic acid, and its molecular structure contains three unstable parts: ester bond, unsaturated double bond and polyphenol. During the plant extraction process, chlorogenic acid often undergoes transformation through hydrolysis and intramolecular ester group migration. Since chlorogenic acid is the main active ingredient of Shuanghuanglian eye drops, a reduction in the chlorogenic acid content may affect the stability of the eye drops quality.

[0006] In the prior art, a Shuanghuanglian eye gel is disclosed in the patent with publication number CN100493493C. However, the above patent only discloses the prescription and preparation method of Shuanghuanglian gel, but does not consider the influence of pesticide residues on quality stability.

[0007] In addition, although the prescription and preparation method of Shuanghuanglian Eye Drops are disclosed in the Shuanghuanglian Eye Drops section of the "Chinese Pharmacopoeia" (2020 edition), the impact of pesticide residues on the quality stability of the eye drops is not studied. Summary of the invention

[0008] The present invention is accomplished in view of the above problems. One solution of the present invention provides a method for improving the quality stability of Shuanghuanglian eye drops, thereby improving the quality stability of Shuanghuanglian eye drops.

[0009] In addition, another embodiment of the present invention provides a method for extracting an extract from a medicinal material for preparing Shuanghuanglian eye drops, thereby improving the quality stability of Shuanghuanglian eye drops.

[0010] In addition, another embodiment of the present invention provides a method for preparing Shuanghuanglian eye drops, thereby improving the quality stability of Shuanghuanglian eye drops.

[0011] In addition, another embodiment of the present invention provides a Shuanghuanglian eye drops with stable quality.

[0012] The inventors have found that when medicinal materials containing residual phosphamidon and oxydemeton-methyl are used to make Shuanghuanglian preparations, such as honeysuckle medicinal materials, the chlorogenic acid content is significantly reduced. By controlling the content of phosphamidon and oxydemeton-methyl in medicinal materials such as honeysuckle medicinal materials, the quality stability of Shuanghuanglian eye drops can be improved.

[0013] Therefore, the present invention includes the following specific embodiments.

[0014] 1. A method for improving the quality stability of Shuanghuanglian eye drops, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, and the method comprises the following steps:

[0015] 1) extracting honeysuckle, scutellaria baicalensis and forsythia suspensa to obtain corresponding medicinal material extracts for preparing Shuanghuanglian eye drops;

[0016] 2) using the obtained medicinal material extract to prepare Shuanghuanglian eye drops;

[0017] Wherein, step 1) comprises:

[0018] - Controlling the content of methamidophos in at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof to be no more than 5 μg / kg, for example, no more than 4 μg / kg, for example, not detected, and the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg, for example, not detected;

[0019] - Extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops.

[0020] 2. The method according to item 1, wherein the content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps:

[0021] - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted;

[0022] If it is detected that the methamidophos content in the at least one medicinal material to be extracted is not more than 5 μg / kg, such as not more than 4 μg / kg, such as not detected, and the omethoate content is not more than 8 μg / kg, such as not more than 6 μg / kg, such as not detected, extraction is performed;

[0023] If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, firstly carry out pesticide residue removal treatment until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg, for example, not detected, and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg, for example, not detected, and then extract;

[0024] Preferably,

[0025] - If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is not more than 4 μg / kg, for example, not detected, and the content of omethoate is not more than 6 μg / kg, for example, not detected, then extraction is performed;

[0026] If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg, for example, not detected, and the content of oxydemeton-methyl is no more than 6 μg / kg, for example, not detected, and then extraction is carried out.

[0027] 3. The method according to item 2, wherein the pesticide residue removal treatment is carried out by supercritical carbon dioxide treatment.

[0028] 4. The method according to any one of items 1 to 3, wherein the at least one medicinal material to be extracted includes or is honeysuckle alone, forsythia suspensa alone, scutellaria baicalensis alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, a combination of forsythia suspensa and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

[0029] 5. The method according to any one of items 1 to 4, wherein the at least one medicinal material to be extracted includes or is honeysuckle alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

[0030] 6. The method according to any one of items 1 to 5, wherein the at least one medicinal material to be extracted includes or is Lonicera japonica alone, and optionally, Fructus Forsythiae alone and / or Radix Scutellariae alone.

[0031] 7. The method according to any one of items 1 to 6, wherein the at least one medicinal material to be extracted comprises honeysuckle, such as honeysuckle alone, and the method comprises:

[0032] - Control the content of methamidophos in the honeysuckle medicinal material to be extracted to be no more than 5 μg / kg, such as no more than 4 μg / kg, such as not detected, and the content of omethoate is no more than 8 μg / kg, such as no more than 6 μg / kg, such as not detected;

[0033] - Extracting the honeysuckle medicinal material to be extracted to obtain the honeysuckle extract for preparing Shuanghuanglian eye drops.

[0034] 8. The method according to item 7, wherein the at least one medicinal material to be extracted further comprises Forsythia suspensa, such as Forsythia suspensa alone, and the method further comprises:

[0035] - Control the content of methamidophos in the forsythia suspensa to be extracted to be no more than 5 μg / kg, for example, no more than 4 μg / kg, for example, not detected, and the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg, for example, not detected;

[0036] - Extracting the Forsythia suspensa medicinal material to be extracted or combining the Forsythia suspensa medicinal material to be extracted with the Honeysuckle medicinal material to be extracted to obtain an extract for preparing Shuanghuanglian eye drops.

[0037] 9. The method according to item 7 or 8, wherein the at least one medicinal material to be extracted further comprises Scutellaria baicalensis, such as Scutellaria baicalensis alone, and the method further comprises:

[0038] -Control the content of methamidophos in the Radix Scutellariae to be extracted to be undetectable, and the content of omethoate to be undetectable;

[0039] - Extracting the Radix Scutellariae Radix to be extracted to obtain the Radix Scutellariae Radix extract for preparing Shuanghuanglian eye drops.

[0040] 10. A method for extracting an extract for preparing Shuanghuanglian eye drops from medicinal materials, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, the method comprising:

[0041] 1) providing at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof;

[0042] 2) controlling the content of methamidophos in the at least one medicinal material to be extracted to be no more than 5 μg / kg, for example, no more than 4 μg / kg, for example, not detected, and the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg, for example, not detected;

[0043] 3) extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops.

[0044] 11. The method according to item 10, wherein the content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps:

[0045] - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted;

[0046] If it is detected that the methamidophos content in the at least one medicinal material to be extracted is not more than 5 μg / kg, such as not more than 4 μg / kg, such as not detected, and the omethoate content is not more than 8 μg / kg, such as not more than 6 μg / kg, such as not detected, extraction is performed;

[0047] If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, firstly carry out pesticide residue removal treatment until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg, for example, not detected, and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg, for example, not detected, and then extract;

[0048] Preferably,

[0049] - If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is not more than 4 μg / kg, for example, not detected, and the content of omethoate is not more than 6 μg / kg, for example, not detected, then extraction is performed;

[0050] If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg, for example, not detected, and the content of oxydemeton-methyl is no more than 6 μg / kg, for example, not detected, and then extraction is carried out.

[0051] 12. The method according to item 11, wherein the pesticide residue removal treatment is carried out by supercritical carbon dioxide treatment.

[0052] 13. The method according to any one of items 10 to 12, wherein the at least one medicinal material to be extracted includes or is Flos Lonicerae alone, Fructus Forsythiae alone, Scutellariae alone, a combination of Flos Lonicerae and Fructus Forsythiae, a combination of Flos Lonicerae and Scutellariae, a combination of Fructus Forsythiae and Scutellariae, or a combination of Flos Lonicerae, Fructus Forsythiae and Scutellariae.

[0053] 14. The method according to any one of items 10 to 13, wherein the at least one medicinal material to be extracted comprises or is honeysuckle alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

[0054] 15. The method according to any one of items 10 to 14, wherein the at least one medicinal material to be extracted includes or is Lonicera japonica alone, and optionally, Fructus Forsythiae alone and / or Radix Scutellariae alone.

[0055] 16. A method for preparing Shuanghuanglian eye drops, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, comprising the following steps:

[0056] 1) extracting honeysuckle, scutellaria baicalensis and forsythia suspensa to obtain corresponding medicinal material extracts;

[0057] 2) using the obtained medicinal material extract to prepare Shuanghuanglian eye drops;

[0058] Wherein at least one selected from the following is prepared by the method according to any one of items 1 to 15: a honeysuckle extract, a scutellaria extract, a forsythia extract, or a combination thereof; preferably, a honeysuckle extract, a forsythia extract, a scutellaria extract, an extract of a combination of honeysuckle and forsythia, an extract of a combination of honeysuckle and scutellaria, an extract of a combination of forsythia and scutellaria, and / or an extract of a combination of honeysuckle, forsythia and scutellaria; preferably, a honeysuckle extract, an extract of a combination of honeysuckle and forsythia, an extract of a combination of honeysuckle and scutellaria, and / or an extract of a combination of honeysuckle, forsythia and scutellaria; preferably, a honeysuckle extract, and / or an extract of a combination of honeysuckle and forsythia.

[0059] 17. Shuanghuanglian eye drops prepared by the method according to any one of items 1 to 16.

[0060] In the present invention, by controlling the contents of methamidophos and oxydemeton-methyl in medicinal materials, especially by controlling the contents of methamidophos and oxydemeton-methyl in honeysuckle medicinal materials, the influence of methamidophos and oxydemeton-methyl on chlorogenic acid during the extraction process can be effectively reduced, the content of chlorogenic acid in the Shuanghuanglian eye drops preparation can be increased, and the situation in which the chlorogenic acid content in the Shuanghuanglian eye drops is reduced or unqualified due to methamidophos and oxydemeton-methyl is avoided, thereby effectively improving the quality stability of the Shuanghuanglian eye drops. DETAILED DESCRIPTION

[0061] In the present invention, unless otherwise specified, the term "undetected" refers to a concentration lower than the detection limit of the detection instrument used in the detection method of the embodiment of the present invention, usually less than 3 times the signal-to-noise ratio.

[0062] The first aspect of the present invention relates to a method for improving the quality stability of Shuanghuanglian eye drops, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, and the method comprises the following steps:

[0063] 1) extracting honeysuckle, scutellaria baicalensis and forsythia suspensa to obtain corresponding medicinal material extracts for preparing Shuanghuanglian eye drops;

[0064] 2) using the obtained medicinal material extract to prepare Shuanghuanglian eye drops;

[0065] Wherein, step 1) comprises:

[0066] - Controlling the content of methamidophos in at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof to be no more than 5 μg / kg, for example, no more than 4 μg / kg, for example, not detected, and the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg, for example, not detected;

[0067] - Extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops.

[0068] In some embodiments of the first aspect of the present invention, the at least one medicinal material to be extracted may include or be a single honeysuckle, a single forsythia, a single scutellaria, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, or a combination of honeysuckle, forsythia and scutellaria. Preferably, the at least one medicinal material to be extracted may include or be a single honeysuckle, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, or a combination of honeysuckle, forsythia and scutellaria. Preferably, the at least one medicinal material to be extracted may include or be a single honeysuckle, and optionally, a single forsythia and / or a single scutellaria. For example, the at least one medicinal material to be extracted may include or be a single honeysuckle.

[0069] In other words, in some embodiments of the first aspect of the present invention, the method can be performed on honeysuckle alone, forsythia alone, scutellaria alone, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, or a combination of honeysuckle, forsythia and scutellaria. For example, the method can be performed on honeysuckle alone, forsythia alone, and scutellaria alone; or on honeysuckle alone, and a combination of forsythia and scutellaria; or on forsythia alone, and a combination of honeysuckle and scutellaria; or on scutellaria alone, and a combination of honeysuckle and forsythia; or on a combination of honeysuckle, forsythia and scutellaria. Of course, those skilled in the art can also imagine that the method can be performed on either individual honeysuckle, individual forsythia, and / or individual scutellaria, or any combination thereof, such as a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, and / or a combination of honeysuckle, forsythia and scutellaria. For example, the method can be performed on either individual honeysuckle, or any combination thereof with forsythia and / or scutellaria, such as a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, or a combination of honeysuckle, forsythia and scutellaria.

[0070] In the present invention, the content of methamidophos in the at least one medicinal material to be extracted is controlled to be no more than 5 μg / kg, and the content of omethoate is no more than 8 μg / kg before extraction. Preferably, in the present invention, the content of methamidophos in the at least one medicinal material to be extracted is controlled to be no more than 4 μg / kg, and the content of omethoate is no more than 6 μg / kg before extraction.

[0071] In some embodiments of the first aspect of the present invention, the content of methamidophos in the at least one medicinal material to be extracted can be controlled to be no more than 5.0 μg / kg, for example, no more than: 4.9, 4.8, 4.7, 4.6, 4.5, 4.4, 4.3, 4.2, 4.1, 4.0, 3.9, 3.8, 3.7, 3.6, 3.5, 3.4, 3.3, 3.2, 3.1, 3.0, 2.9, 2.8, 2.7, 2.6, 2.5, 2.4, 2.3, 2.2, 2.1, 2.0, 1.9, 1.8, 1.7, 1.6, 1.5, 1.4, 1.3, 1.2, 1.1, 1.0, 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, 0.1 μg / kg, or controlled to undetectable or even about 0 μg / kg.

[0072] In some embodiments of the first aspect of the present invention, the content of omethoate in the at least one medicinal material to be extracted can be controlled to be no more than 8.0 μg / kg, for example, no more than: 7.9, 7.8, 7.7, 7.6, 7.5, 7.4, 7.3, 7.2, 7.1, 7.0, 6.9, 6.8, 6.7, 6.6, 6.5, 6.4, 6.3, 6.2, 6.1, 6.0, 5.9, 5.8, 5.7, 5.6, 5.5, 5.4, 5.3, 5.2, 5.1, 5.0, 4.9, 4.8, 4.7, 4.6, 4.5, 4.4, 4.3, 4.2, 4.1, 4.0, 3.9, 3.8, 3.7, 3.6, 3.5, 3.4, 3.3, 3.2, 3.1, 3.0, 2.9, 2.8, 2.7, 2.6, 2.5, 2.4, 2.3, 2.2, 2.1, 2.0, 1.9, 1.8, 1.7, 1.6, 1.5, 1.4, 1.3, 1.2, 1.1, 1.0, 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, 0.1 μg / kg, or controlled to undetectable or even about 0 μg / kg.

[0073] In some embodiments of the first aspect of the present invention, the content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps:

[0074] - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted;

[0075] - if it is detected that the methamidophos content in the at least one medicinal material to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the omethoate content is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, then extraction is performed;

[0076] If the content of methamidophos in the at least one medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or not detected and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or not detected, and then extraction is performed;

[0077] Preferably,

[0078] - If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is not more than 4 μg / kg or is not detected, and the content of omethoate is not more than 6 μg / kg or is not detected, extraction is performed;

[0079] If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6 μg / kg or is not detected, and then extraction is carried out.

[0080] In one embodiment of the first aspect of the present invention, the medicinal material to be extracted includes or is honeysuckle alone, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, or a combination of honeysuckle, forsythia and scutellaria. Therefore, in this embodiment, step 1) of the method includes:

[0081] - controlling the content of methamidophos in at least one medicinal material to be extracted selected from the group consisting of honeysuckle alone, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, or a combination of honeysuckle, forsythia and scutellaria to be no more than 5 μg / kg, for example, no more than 4 μg / kg, or not detected, and the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg, or not detected;

[0082] - extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops;

[0083] Preferably, the content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps:

[0084] - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted;

[0085] - if it is detected that the methamidophos content in the at least one medicinal material to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the omethoate content is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, then extraction is performed;

[0086] If the content of methamidophos in the at least one medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or not detected and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or not detected, and then extraction is performed;

[0087] Preferably,

[0088] - If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is not more than 4 μg / kg or is not detected, and the content of omethoate is not more than 6 μg / kg or is not detected, extraction is performed;

[0089] If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6 μg / kg or is not detected, and then extraction is carried out.

[0090] In some embodiments of the first aspect of the present invention, the medicinal material to be extracted includes honeysuckle, for example, includes or is honeysuckle alone. Therefore, in this embodiment, step 1) of the method includes:

[0091] - Control the content of methamidophos in the honeysuckle medicinal material to be extracted to be no more than 5 μg / kg, for example, no more than 4 μg / kg or undetected, and the content of omethoate is no more than 8 μg / kg, for example, no more than 6 μg / kg or undetected;

[0092] - extracting the honeysuckle medicinal material to be extracted to obtain the honeysuckle medicinal material extract for preparing Shuanghuanglian eye drops;

[0093] Preferably, the contents of methamidophos and omethoate in the honeysuckle medicinal material to be extracted are controlled by the following steps:

[0094] - detecting the contents of methamidophos and omethoate in the honeysuckle medicinal material to be extracted;

[0095] - If it is detected that the content of methamidophos in the honeysuckle medicinal material to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the content of omethoate is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, extraction is performed;

[0096] If it is detected that the content of methamidophos in the honeysuckle medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or is not detected and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or is not detected, and then extraction is performed;

[0097] Preferably,

[0098] - If it is detected that the content of methyl parathion in the honeysuckle medicinal material to be extracted is not more than 4 μg / kg or not detected, and the content of omethoate is not more than 6 μg / kg or not detected, extraction is performed;

[0099] If it is detected that the content of methyl parathion in the honeysuckle medicinal material to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6 μg / kg or is not detected, and then extraction is carried out.

[0100] In some embodiments of the first aspect of the present invention, alternatively or additionally, the at least one medicinal material to be extracted includes or is Fructus Forsythiae alone, a combination of Flos Lonicerae and Fructus Forsythiae, a combination of Fructus Forsythiae and Radix Scutellariae, or a combination of Flos Lonicerae, Fructus Forsythiae, and Radix Scutellariae. Therefore, in the present invention, Fructus Forsythiae can be processed according to the above method, or in addition to processing Flos Lonicerae according to the above method, Fructus Forsythiae can also be processed according to the above method.

[0101] Thus, in some embodiments, alternatively or additionally, the method comprises:

[0102] - controlling the content of methamidophos in at least one medicinal material to be extracted selected from the group consisting of Forsythia suspensa alone, a combination of Forsythia suspensa and honeysuckle, a combination of Forsythia suspensa and scutellaria baicalensis, a combination of Forsythia suspensa, honeysuckle and scutellaria baicalensis to be no more than 5 μg / kg, for example, no more than 4 μg / kg, or not detected, and controlling the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg, or not detected;

[0103] - extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops;

[0104] Preferably, the content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps:

[0105] - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted;

[0106] - if it is detected that the methamidophos content in the at least one medicinal material to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the omethoate content is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, then extraction is performed;

[0107] If the content of methamidophos in the at least one medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or not detected and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or not detected, and then extraction is performed;

[0108] Preferably,

[0109] - If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is not more than 4 μg / kg or is not detected, and the content of omethoate is not more than 6 μg / kg or is not detected, extraction is performed;

[0110] If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6 μg / kg or is not detected, and then extraction is carried out.

[0111] In some embodiments of the first aspect of the present invention, alternatively or additionally, the medicinal material to be extracted includes Forsythia suspensa, for example, includes or is Forsythia suspensa alone. Therefore, in this embodiment, alternatively or additionally, the method includes:

[0112] - Control the content of methamidophos in the forsythia suspensa to be extracted to be no more than 5 μg / kg, for example, no more than 4 μg / kg or undetected, and the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg or undetected;

[0113] - extracting the Forsythia suspensa medicinal material to be extracted or combining the Forsythia suspensa medicinal material to be extracted with the honeysuckle medicinal material to be extracted (i.e., in the case of combined extraction, mixing the honeysuckle with the Forsythia suspensa medicinal material after the content of methamidophos and omethoate is controlled and then extracting), so as to obtain an extract for preparing Shuanghuanglian eye drops;

[0114] Preferably, the contents of methamidophos and omethoate in the forsythia suspensa medicinal material to be extracted are controlled by the following steps:

[0115] - detecting the contents of methamidophos and omethoate in the forsythia suspensa medicinal material to be extracted;

[0116] - If it is detected that the content of methamidophos in the Forsythia suspensa medicinal material to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the content of omethoate is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, extraction is performed;

[0117] If it is detected that the content of methamidophos in the forsythia suspensa to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or not detected and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or not detected, and then extraction is performed;

[0118] Preferably,

[0119] - If it is detected that the content of methamidophos in the Forsythia suspensa to be extracted is not more than 4 μg / kg or not detected, and the content of omethoate is not more than 6 μg / kg or not detected, extraction is performed;

[0120] If it is detected that the content of methyl parathion in the Forsythia suspensa to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6 μg / kg or is not detected, and then extraction is carried out.

[0121] In some embodiments of the first aspect of the present invention, alternatively or additionally, the at least one medicinal material to be extracted includes or is a single scutellaria baicalensis, a combination of honeysuckle and scutellaria baicalensis, a combination of forsythia suspensa and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis. Therefore, in the present invention, scutellaria baicalensis can be processed according to the above method, or in addition to processing honeysuckle according to the above method, scutellaria baicalensis can also be processed according to the above method, or in addition to processing forsythia suspensa according to the above method, scutellaria baicalensis can also be processed according to the above method, or in addition to processing honeysuckle and scutellaria baicalensis according to the above method, scutellaria baicalensis can also be processed according to the above method.

[0122] Thus, in some embodiments, alternatively or additionally, the method comprises:

[0123] - controlling the content of methamidophos in at least one medicinal material to be extracted selected from the group consisting of single scutellaria baicalensis, a combination of honeysuckle and scutellaria baicalensis, a combination of forsythia suspensa and scutellaria baicalensis, a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis to be no more than 5 μg / kg, for example, no more than 4 μg / kg, or not detected, and controlling the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg, or not detected;

[0124] - extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops;

[0125] Preferably, the content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps:

[0126] - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted;

[0127] - if it is detected that the methamidophos content in the at least one medicinal material to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the omethoate content is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, then extraction is performed;

[0128] If the content of methamidophos in the at least one medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or not detected and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or not detected, and then extraction is performed;

[0129] Preferably,

[0130] - If it is detected that the content of methamidophos in the at least one medicinal material to be extracted is not more than 4 μg / kg or is not detected, and the content of omethoate is not more than 6 μg / kg or is not detected, extraction is performed;

[0131] If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6 μg / kg or is not detected, and then extraction is carried out.

[0132] In some embodiments of the first aspect of the present invention, alternatively or additionally, the medicinal material to be extracted includes Scutellaria baicalensis, for example, includes or is Scutellaria baicalensis alone. Therefore, in this embodiment, alternatively or additionally, the method includes:

[0133] -Control the content of methamidophos in the Radix Scutellariae to be extracted to be undetectable, and the content of omethoate to be undetectable;

[0134] - extracting the Radix Scutellariae Radix to be extracted to obtain the Fructus Forsythiae Fructus extract for preparing Shuanghuanglian eye drops;

[0135] Preferably, the contents of methamidophos and omethoate in the forsythia suspensa medicinal material to be extracted are controlled by the following steps:

[0136] - detecting the contents of methamidophos and omethoate in the Radix Scutellariae to be extracted;

[0137] - if it is detected that the content of methamidophos in the Radix Scutellariae to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the content of omethoate is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, then extraction is performed;

[0138] If the content of methamidophos in the Radix Scutellariae to be extracted is detected to be greater than 5 μg / kg and / or the content of omethoate is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or not detected and the content of omethoate is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or not detected, and then extraction is performed;

[0139] Preferably,

[0140] - If it is detected that the content of methamidophos in the Radix Scutellariae to be extracted is not more than 4 μg / kg or is not detected, and the content of omethoate is not more than 6 μg / kg or is not detected, extraction is performed;

[0141] If it is detected that the content of methyl parathion in the Scutellaria baicalensis medicinal material to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6 μg / kg or is not detected, and then extraction is carried out.

[0142] In some embodiments of the first aspect of the present invention, the pesticide residue removal treatment is performed by supercritical carbon dioxide treatment (ie, treatment using supercritical carbon dioxide), or by soaking at room temperature using water as a solvent.

[0143] The extraction step can be performed by any suitable method known in the art, as long as the effective ingredients for preparing Shuanghuanglian eye drops can be effectively extracted. The extraction step can be performed using any suitable known solvent such as water, ethanol, etc.

[0144] In some embodiments of the first aspect of the present invention, the extraction of a single honeysuckle medicinal material can be carried out, for example, by: optionally soaking with water (for example, at room temperature), and then extracting at a temperature above room temperature, for example, decocting with water once, twice or more times; filtering the (for example, combined) extract such as the decoction, and concentrating to remove water; then extracting with ethanol, concentrating the extract to remove ethanol, then adding water to extract, concentrating the extract to remove water, adding ethanol to extract, and concentrating the extract to remove ethanol.

[0145] In some embodiments of the first aspect of the present invention, the extraction of a single honeysuckle medicinal material can be carried out, for example, by the method described in the Chinese Pharmacopoeia (2020 edition) Volume 1: Formula Preparation Shuanghuanglian Eye Drops (page 778). In some specific embodiments of the first aspect of the present invention, the extraction method for a single honeysuckle can be carried out, for example, as follows: After the honeysuckle is soaked in water for 30 minutes, it is decocted twice, each time for 1 hour, the decoction is combined and filtered, and the filtrate is concentrated to a clear paste with a relative density of 1.20 to 1.25 (70°C), cooled to 40°C, ethanol is slowly added to make the alcohol content reach 75%, stirred thoroughly, and allowed to stand for 12 hours, the supernatant is filtered, and the ethanol is recovered until there is no alcohol taste, water is added and allowed to stand for 12 hours, the supernatant is filtered, and the relative density is 1.10 to 1.15 (80°C) Clear paste, cooled to 40°C, ethanol is added to make the alcohol content reach 85%, and allowed to stand for more than 12 hours, the supernatant is filtered, and the ethanol is recovered until there is no alcohol taste, and an extract is obtained.

[0146] The extraction method of the honeysuckle medicinal material is not limited thereto, as long as the effective ingredients for preparing Shuanghuanglian eye drops can be effectively extracted.

[0147] In some embodiments of the first aspect of the present invention, the extraction of individual Forsythia suspensa medicinal materials can be carried out, for example, by: optionally soaking with water (for example, at room temperature), and then extracting at a temperature above room temperature, for example, decocting with water once, twice or more times; filtering the (for example, combined) extract such as the decoction, and concentrating to remove water; then extracting with ethanol, concentrating the extract to remove ethanol, then adding water to extract, concentrating the extract to remove water, adding ethanol to extract, and concentrating the extract to remove ethanol.

[0148] In some embodiments of the first aspect of the present invention, the extraction of a single Forsythia suspensa medicinal material can be carried out, for example, by the method described in the Chinese Pharmacopoeia (2020 edition) Part I: Formula preparations and single-ingredient preparations Shuanghuanglian eye drops (page 778). In some specific embodiments of the first aspect of the present invention, the extraction method for a single Forsythia suspensa can be carried out, for example, as follows: After Forsythia suspensa is soaked in water for 30 minutes, it is decocted twice, each time for 1 hour, the combined decoction is filtered, and the filtrate is concentrated to a clear paste with a relative density of 1.20 to 1.25 (70°C), cooled to 40°C, ethanol is slowly added to make the alcohol content reach 75%, stirred thoroughly, and allowed to stand for 12 hours, the supernatant is filtered, and the ethanol is recovered until there is no alcohol taste, water is added and allowed to stand for 12 hours, the supernatant is filtered, and the relative density is 1.10 to 1.15 (80°C) Clear paste, cooled to 40°C, ethanol is added to make the alcohol content reach 85%, and allowed to stand for more than 12 hours, the supernatant is filtered, and the ethanol is recovered until there is no alcohol taste, and an extract is obtained.

[0149] The extraction method of the Forsythia suspensa medicinal material is not limited thereto, as long as the effective ingredients for preparing Shuanghuanglian eye drops can be effectively extracted.

[0150] In some embodiments of the first aspect of the present invention, the extraction of a single Radix Scutellariae Radix can be performed, for example, by: optionally soaking with water (for example, at room temperature), then extracting at a temperature above room temperature, for example, decocting with water once, twice or more times, filtering the (for example, combined) extract, for example, the decoction, adjusting the pH with an acid (for example, hydrochloric acid) (for example, to 1.0-2.0), filtering, mixing the precipitate with water, adjusting the pH with an alkali (for example, NaOH) (for example, to neutral, for example, equal to or lower than 7.0, for example, 6.0-7.0), adding ethanol, mixing, dissolving and filtering, adjusting the pH of the filtrate with an acid (for example, hydrochloric acid) (for example, to 1.0-2.0) and filtering, washing the precipitate with ethanol (for example, to pH 4.0), add water, adjust the pH with a base (such as NaOH) (for example, to neutral, such as equal to or lower than 7.0, such as 6.0-7.0), add activated carbon and mix, then add ethanol and mix, then filter, adjust the pH of the filtrate with an acid (such as hydrochloric acid) (for example, to 1.0-2.0), filter, wash the precipitate with ethanol, and dry.

[0151] In some embodiments of the first aspect of the present invention, the extraction of a single Radix Scutellariae Radix can be performed, for example, by the method described in the Chinese Pharmacopoeia (2020 Edition) Volume 1: Formula Preparations and Single Preparation Shuanghuanglian Eye Drops (page 778). In some specific embodiments of the first aspect of the present invention, the extraction method for a single Radix Scutellariae Radix can be performed, for example, as follows: Radix Scutellariae Radix is ​​decocted with water twice, each time for 1 hour, combined and filtered, the filtrate is adjusted to a pH value of 1.0 to 2.0 with 2 mol / L hydrochloric acid solution, kept warm at 80°C for 30 minutes, left to stand for 24 hours, filtered, the precipitate is stirred with water, the pH value is adjusted to 6.0 to 7.0 with 40% sodium hydroxide solution, an equal amount of ethanol is added, stirred to dissolve, filtered, and the filtrate is adjusted to a pH value of 2. 0, keep warm at 80°C for 30 minutes, let stand for 12 hours, filter, wash the precipitate with ethanol until the pH value reaches 4.0, add water and stir, adjust the pH value to 6.0-7.0 with 40% sodium hydroxide solution, add 0.5% activated carbon, stir well, keep warm at 50°C for 30 minutes, add ethanol and stir evenly, filter immediately, adjust the pH value of the filtrate to 2.0 with 2mol / L hydrochloric acid solution, keep warm at 80°C for 30 minutes, let stand for 12 hours, filter, wash the precipitate with a small amount of ethanol, and dry it below 60°C to obtain an extract.

[0152] The extraction method of the scutellaria baicalensis medicinal material is not limited thereto, as long as the effective ingredients for preparing Shuanghuanglian eye drops can be effectively extracted.

[0153] As described above, in the present invention, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, or a combination of honeysuckle, forsythia and scutellaria may be extracted.

[0154] For example, in some embodiments of the first aspect of the present invention, a combination of honeysuckle and forsythia can be extracted.

[0155] Extraction of the combination (i.e., mixture) of honeysuckle and forsythia can be carried out, for example, by: optionally soaking with water (e.g., at room temperature), then extracting at a temperature above room temperature, for example, decocting with water once, twice or more times; filtering the (e.g., combined) extract such as the decoction, and concentrating to remove water; then extracting with ethanol, concentrating the extract to remove ethanol, then adding water to extract, concentrating the extract to remove water, adding ethanol to extract, and concentrating the extract to remove ethanol.

[0156] In some embodiments of the first aspect of the present invention, the extraction of the combination of honeysuckle and forsythia can be carried out, for example, by the method described in the Chinese Pharmacopoeia (2020 edition) Volume 1: Formula Preparations and Single-Ingredient Preparations Shuanghuanglian Eye Drops (page 778). In some specific embodiments of the first aspect of the present invention, the extraction method for the combination of honeysuckle and forsythia can be carried out, for example, as follows: after soaking honeysuckle and forsythia in water for 30 minutes respectively, decocting twice, each time for 1 hour, combining the decoctions and filtering, concentrating the filtrate to a clear paste with a relative density of 1.20-1.25 (70°C), cooling to 40°C, slowly adding ethanol to make the alcohol content reach 75%, stirring thoroughly, standing for 12 hours, filtering the supernatant, recovering ethanol until there is no alcohol taste, adding water and standing for 12 hours, filtering the supernatant, concentrating to a clear paste with a relative density of 1.10-1.15 (80°C), cooling to 40°C, adding ethanol to make the alcohol content reach 85%, standing for more than 12 hours, filtering the supernatant, recovering ethanol until there is no alcohol taste, and obtaining an extract.

[0157] The extraction method of the combination of honeysuckle and forsythia is not limited thereto, as long as the effective ingredients for preparing Shuanghuanglian eye drops can be effectively extracted.

[0158] In the present invention, pesticide residue removal and extraction can be carried out in the following manners, for example but not limited to:

[0159] (1) removing pesticide residues from honeysuckle, scutellaria baicalensis, and forsythia suspensa, respectively, and then extracting them respectively;

[0160] (2) performing pesticide residue removal treatment on individual honeysuckle, individual scutellaria, and individual forsythia, respectively, and then extracting the pesticide residue-free medicinal material combination (e.g., a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, or a combination of honeysuckle, forsythia and scutellaria);

[0161] (3) treating a combination of honeysuckle, scutellaria, and forsythia (e.g., a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, or a combination of honeysuckle, forsythia, and scutellaria) to remove pesticide residues, and then extracting the combination after the pesticide residue removal treatment;

[0162] or

[0163] (4) Any combination of (1) to (3) above.

[0164] In some embodiments of the first aspect of the present invention, the content of methamidophos in at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof originally provided in step 1) is greater than 5 μg / kg, and / or the content of omethoate is greater than 8 μg / kg. In some embodiments of the first aspect of the present invention, the content of methamidophos in at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof originally provided in step 1) is greater than 4 μg / kg, and / or the content of omethoate is greater than 6 μg / kg. For example, the content of methamidophos in the honeysuckle medicinal material to be extracted is greater than 4 μg / kg, and / or the content of omethoate is greater than 6 μg / kg; the content of methamidophos in the forsythia medicinal material to be extracted is greater than 4 μg / kg, and / or the content of omethoate is greater than 6 μg / kg; and / or the content of methamidophos in the scutellaria medicinal material to be extracted is greater than 4 μg / kg, and / or the content of omethoate is greater than 6 μg / kg. In other words, the present invention can use medicinal materials containing high-methyl parathion and oxydemeton-methyl pesticide residues to prepare Shuanghuanglian eye drops with stable quality.

[0165] The second aspect of the present invention relates to a method for extracting an extract from medicinal materials for preparing Shuanghuanglian eye drops, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, and the method comprises:

[0166] 1) providing at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof;

[0167] 2) controlling the content of methamidophos in the at least one medicinal material to be extracted to be no more than 5 μg / kg, for example, no more than 4 μg / kg or not detected, and controlling the content of omethoate to be no more than 8 μg / kg, for example, no more than 6 μg / kg or not detected;

[0168] 3) extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops.

[0169] In some embodiments of the second aspect of the present invention, the method controls the content of methamidophos and omethoate in the at least one medicinal material to be extracted by the following steps:

[0170] - Detect the content of methamidophos and omethoate in the medicinal materials to be extracted;

[0171] - if it is detected that the content of methamidophos in the medicinal material to be extracted is not more than 5 μg / kg, for example, not more than 4 μg / kg or not detected, and the content of omethoate is not more than 8 μg / kg, for example, not more than 6 μg / kg or not detected, extraction is performed;

[0172] If the content of methamidophos in the medicinal material to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first performed until the content of methamidophos is not greater than 5 μg / kg, for example, not greater than 4 μg / kg or not detected and the content of oxydemeton-methyl is not greater than 8 μg / kg, for example, not greater than 6 μg / kg or not detected, and then extraction is performed;

[0173] Preferably,

[0174] - If the content of methamidophos in the medicinal material to be extracted is not more than 4 μg / kg or not detected, and the content of omethoate is not more than 6 μg / kg or not detected, extraction is carried out;

[0175] If it is detected that the content of methyl parathion in the medicinal materials to be extracted is greater than 4μg / kg and / or the content of oxydemeton-methyl is greater than 6μg / kg, pesticide residue removal treatment shall be carried out first until the content of methyl parathion is no more than 4μg / kg or is not detected and the content of oxydemeton-methyl is no more than 6μg / kg or is not detected, and then extraction shall be carried out.

[0176] In some embodiments of the second aspect of the present invention, the pesticide residue removal treatment is performed by supercritical carbon dioxide treatment, or by soaking with water as a solvent at room temperature.

[0177] In some embodiments of the second aspect of the present invention, the at least one medicinal material to be extracted includes or is honeysuckle alone, forsythia alone, scutellaria alone, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, or a combination of honeysuckle, forsythia and scutellaria; preferably, the at least one medicinal material to be extracted includes or is honeysuckle alone, a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, or a combination of honeysuckle, forsythia and scutellaria; preferably, the at least one medicinal material to be extracted includes or is honeysuckle alone, and optionally, forsythia alone and / or scutellaria alone. For example, the at least one medicinal material to be extracted may include or be honeysuckle alone.

[0178] In other words, the method of the second aspect of the present invention can be used to extract the corresponding extracts from honeysuckle alone, forsythia alone, and scutellaria alone, respectively. The corresponding extracts can also be extracted from any combination thereof (e.g., a combination of honeysuckle and forsythia, a combination of honeysuckle and scutellaria, a combination of forsythia and scutellaria, or a combination of honeysuckle, forsythia and scutellaria).

[0179] The above description on the method of the first aspect is also applicable to the method of the second aspect.

[0180] The third aspect of the present invention relates to a method for preparing Shuanghuanglian eye drops, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, and the method comprises the following steps:

[0181] 1) extracting honeysuckle, scutellaria baicalensis and forsythia suspensa to obtain corresponding medicinal material extracts;

[0182] 2) using the obtained medicinal material extract to prepare Shuanghuanglian eye drops;

[0183] Wherein at least one selected from the following: honeysuckle extract, scutellaria baicalensis extract, forsythia suspensa extract, or a combination thereof is prepared by the method according to any embodiment of the first aspect or the second aspect.

[0184] In some embodiments of the third aspect of the present invention, at least one selected from the following is prepared by the method according to any embodiment of the first aspect or the second aspect: a honeysuckle extract, a forsythia extract, a scutellaria extract, an extract of a combination of honeysuckle and forsythia, an extract of a combination of honeysuckle and scutellaria, an extract of a combination of forsythia and scutellaria, and / or an extract of a combination of honeysuckle, forsythia and scutellaria.

[0185] In some embodiments of the third aspect of the present invention, at least one selected from the following is prepared by the method described in any embodiment of the first aspect or the second aspect: a honeysuckle extract, an extract of a combination of honeysuckle and Forsythia suspensa, an extract of a combination of honeysuckle and Scutellaria baicalensis, and / or an extract of a combination of honeysuckle, Forsythia suspensa and Scutellaria baicalensis.

[0186] In some embodiments of the third aspect of the present invention, the honeysuckle extract and / or the extract of the combination of honeysuckle and forsythia suspensa is prepared by the method according to any embodiment of the first aspect or the second aspect.

[0187] The above description on the first and second aspects also applies to the third aspect.

[0188] The fourth aspect of the present invention relates to Shuanghuanglian eye drops, which are prepared by the method according to the first aspect, the second aspect, or the third aspect.

[0189] In particular, the fourth aspect of the present invention includes, but is not limited to, the following:

[0190] - When honeysuckle, forsythia, and scutellaria are extracted separately according to the method of the first, second, or third aspect, the prepared honeysuckle extract, forsythia extract, and scutellaria extract are combined and formulated into Shuanghuanglian eye drops.

[0191] When the combination of honeysuckle and forsythia suspensa and scutellaria baicalensis alone are extracted according to the method of the first, second or third aspect, the prepared extract of the combination of honeysuckle and forsythia suspensa is combined with a scutellaria baicalensis extract and formulated into Shuanghuanglian eye drops.

[0192] When the combination of honeysuckle and scutellaria and Forsythia suspensa alone are extracted according to the method of the first, second or third aspect, the prepared extract of the combination of honeysuckle and scutellaria is combined with Forsythia suspensa extract and formulated into Shuanghuanglian eye drops.

[0193] - When the individual honeysuckle, scutellaria baicalensis and forsythia suspensa combination are extracted according to the method of the first aspect, the second aspect, or the third aspect, the prepared honeysuckle extract, forsythia suspensa and scutellaria baicalensis combination extract are combined and formulated into Shuanghuanglian eye drops.

[0194] - When the combination of honeysuckle, forsythia and scutellaria is extracted according to the method of the first aspect, the second aspect, or the third aspect, the prepared extract of the combination of honeysuckle, forsythia and scutellaria is formulated into Shuanghuanglian eye drops.

[0195] The method of using the above medicinal material extracts to prepare Shuanghuanglian eye drops is well known in the art. For example, it can be prepared according to the method described in the patent CN1220501C of the applicant.

[0196] The inventors found that by using the method of the present invention to prepare Shuanghuanglian eye drops, due to the control of the content of methamidophos and oxydemeton-methyl in honeysuckle, forsythia and / or scutellaria before extraction, the influence of methamidophos and oxydemeton-methyl on chlorogenic acid during the extraction process can be effectively reduced, and the influence of the residual methamidophos and oxydemeton-methyl after extraction on the chlorogenic acid in Shuanghuanglian eye drops can be avoided, thereby avoiding the situation in which the chlorogenic acid content in Shuanghuanglian eye drops is reduced or unqualified due to methamidophos and oxydemeton-methyl, so that the chlorogenic acid content between different batches of products remains basically consistent.

[0197] Example

[0198] The embodiments of the present invention will be described in detail below with reference to examples. However, the following examples are only used to illustrate the present invention and should not be regarded as limiting the scope of the present invention.

[0199] For the purpose of laboratory research, the inventors studied the effects of methamidophos and oxydemeton-methyl pesticide residues in three Chinese medicinal materials on the chlorogenic acid content and the stability of eye drops, and through a large number of experimental studies, determined the maximum theoretical residue limits of methamidophos and oxydemeton-methyl in honeysuckle, scutellaria, and forsythia, ensuring that the effective content of chlorogenic acid is not affected, thereby also affecting the stability of the eye drops.

[0200] In the following embodiments, the inventors of the present application purchased honeysuckle produced in Shandong and Hubei, scutellaria produced in Inner Mongolia and Shanxi, and forsythia produced in Henan and Shanxi, respectively, and detected the contents of chlorogenic acid, methyl parathion, and oxydemeton-methyl in the medicinal materials by the following methods, and conducted the following experiments.

[0201] Experimental Example 1 Effect of Pesticide Residues in Honeysuckle Flos on Chlorogenic Acid:

[0202] Experiment 1-1 selected medicinal materials with and without methamidophos and oxydemeton-methyl for extraction, respectively, to examine the effect of the two pesticide residues on chlorogenic acid in the extraction process of honeysuckle.

[0203] The extraction process is as follows: 250g of honeysuckle is soaked in water for 30 minutes, decocted twice, each time for 1 hour, the decoction is combined and filtered, the filtrate is concentrated to a clear paste with a relative density of 1.20-1.25 (70°C), cooled to 40°C, ethanol is slowly added to make the alcohol content reach 75%, fully stirred, allowed to stand for 12 hours, the supernatant is filtered out, the ethanol is recovered until there is no alcohol taste, water is added and allowed to stand for 12 hours, the supernatant is filtered out, concentrated to a clear paste with a relative density of 1.10-1.15 (80°C), cooled to 40°C, ethanol is added to make the alcohol content reach 85%, allowed to stand for more than 12 hours, the supernatant is filtered out, and the ethanol is recovered until there is no alcohol taste, thereby obtaining an extract.

[0204] In the above extraction process, the decoction is completed (i.e., "decoction twice, each time for 1 hour, combined decoction and filtered", which is step 1), the concentration is completed (i.e., "the filtrate is concentrated to a clear paste with a relative density of 1.20-1.25 (70° C.)" in the above extraction, which is step 2), and the 75% alcohol precipitation and concentration are completed (i.e., "cooling to 40° C., slowly adding ethanol to make the alcohol content reach 75%, fully stirring, standing for 12 hours, filtering the supernatant, and recovering ethanol until there is no alcohol taste" in the above extraction, which is step 3), water precipitation and concentration are completed (i.e., "add water and let stand for 12 hours, filter out the supernatant, and concentrate to a clear paste with a relative density of 1.10-1.15 (80°C)" in the above extraction, which is step 4), and 85% alcohol precipitation and concentration are completed (i.e., "cool to 40°C, add ethanol to make the alcohol content reach 85%, let stand for more than 12 hours, filter out the supernatant, and recover the ethanol until there is no alcohol taste" in the above extraction, which is step 5), and then the content of methyl parathion, oxydemeton-methyl pesticides and chlorogenic acid in the samples of each step are detected.

[0205] The detection methods of methamidophos and oxydemeton-methyl are as follows: refer to the method in the literature: "Residue Status and Risk Assessment of Organophosphorus Prohibited and Restricted Pesticides in Honeysuckle" (Li Jiaxin, Shi Shangmei, Xue Jian, Chinese Journal of Traditional Chinese Medicine, June 2018, Vol. 43, No. 11). Use Agilent 7890A gas chromatograph (FPD detector), HP-5 capillary column (0.25μm×0.32mm×30m), injection port temperature 250℃, non-split injection, heating program: initial temperature 80℃, 10℃·min -1 Raise to 170℃, 5℃·min -1 Raise to 190℃, at 2℃·min -1 Raise to 200℃, 10℃·min-1 Raise to 250℃ and maintain for 14min; detector temperature 250℃; carrier gas is nitrogen, constant pressure 6.71psi (1psi=6.895kPa); hydrogen flow rate 75mL·min -1 , air flow rate 60mL·min -1 , injection volume 1μL, quantitative detection by external standard method.

[0206] The chlorogenic acid detection method is as follows: refer to the determination item of honeysuckle content in Shuanghuanglian eye drops in the Chinese Pharmacopoeia in 2020. Use high performance liquid chromatography, octadecylsilane bonded silica gel as filler; methanol-water-glacial acetic acid (20:80:1) as mobile phase; detection wavelength is 324nm, and external standard method is used for quantitative detection.

[0207] The effects of methamidophos and oxydemeton-methyl on the chlorogenic acid content during the extraction of honeysuckle are shown in Table 1 below:

[0208] Table 1 Effect of the presence or absence of methamidophos and omethoate residues on the chlorogenic acid content in the extraction process of honeysuckle

[0209]

[0210] Note: “-” means not detected or not contained.

[0211] The results showed that the residues of two pesticides, methamidophos and oxydemeton-methyl, would affect the content of chlorogenic acid, the effective substance of honeysuckle during the extraction process.

[0212] Experiments 1-2 used different amounts of methamidophos and omethoate to extract medicinal materials, respectively, to investigate the effects of the residues of these two pesticides on chlorogenic acid in the extraction process of honeysuckle and forsythia:

[0213] The extraction method and the detection methods of chlorogenic acid, methamidophos and omethoate are the same as those in the example of Experiment 1-1. The effects of the residues of methamidophos and omethoate on the chlorogenic acid content in the extraction process of honeysuckle are shown in Table 2 below:

[0214] Table 2 Effects of different residual amounts of methamidophos and omethoate on the content of chlorogenic acid in the extraction process of honeysuckle

[0215]

[0216]

[0217] The above example results prove that:

[0218] (1) The more methamidophos and omethoate residues there were, the greater the impact on the content of chlorogenic acid, the effective substance of honeysuckle, during the extraction process;

[0219] (2) In Example 7, when 250 g of honeysuckle contained 1.93 μg of methamidophos and 2.88 μg of omethoate, that is, when honeysuckle contained 7.72 μg / kg of methamidophos and 11.52 μg / kg of omethoate, the effect of pesticide residues on the extraction amount of the effective substance chlorogenic acid was significantly reduced. In Example 8, when 250 g of honeysuckle contained 1.04 μg of methamidophos and 1.61 μg of omethoate, that is, when honeysuckle contained 4.16 μg / kg of methamidophos and 6.44 μg / kg of omethoate, the pesticide residues had little effect on the extraction amount of the effective substance chlorogenic acid.

[0220] (3) Therefore, when the residual amount of methyl parathion in honeysuckle is controlled below 5 μg / kg, for example, further controlled to below 4 μg / kg, and the residual amount of oxydemeton-methyl is controlled below 8 μg / kg, for example, further controlled to below 6 μg / kg, there is basically no effect on the extraction amount of the effective substance chlorogenic acid.

[0221] Experimental Example 2 Effect of pesticide residues in Radix Scutellariae on chlorogenic acid:

[0222] Scutellaria baicalensis without methamidophos and oxydemeton-methyl and Scutellaria baicalensis containing methamidophos and oxydemeton-methyl were selected for extraction respectively, and the effects of methamidophos and oxydemeton-methyl pesticide residues in Scutellaria baicalensis extract on the active ingredient chlorogenic acid during the preparation process were investigated.

[0223] The extraction process of Radix Scutellariae is as follows: take 250g Radix Scutellariae, add water and boil twice (8, 6 times the amount) for 1 hour each time, combine and filter, adjust the pH value of the filtrate to 1.0-2.0 with 2mol / L hydrochloric acid solution, keep warm at 80℃ for 30 minutes, let stand for 24 hours, filter, add 8 times the amount of water to the precipitate, stir, adjust the pH value to 6.0-7.0 with 40% sodium hydroxide solution, add an equal amount of ethanol, stir to dissolve, filter, adjust the pH value of the filtrate to 2.0 with 2mol / L hydrochloric acid solution, keep warm at 80℃ for 30 minutes, let stand for 12 hours, filter, wash the precipitate with ethanol until the pH value reaches 4.0, add 10 times the amount of water, stir, adjust the pH value to 6.0-7.0 with 40% sodium hydroxide solution, add 0.5% activated carbon, stir well, keep warm at 50℃ for 30 minutes, add 1-2 times the amount of ethanol and stir evenly, filter immediately, adjust the pH value of the filtrate to 2.0 with 2mol / L hydrochloric acid solution, keep warm at 80℃ for 30 minutes, let stand for 12 hours, filter, wash the precipitate with a small amount of ethanol, and dry it below 60℃.

[0224] The decocting in the above extraction process was completed (i.e., "decocting twice with water (8, 6 times the amount) for 1 hour each time, combining and filtering" in the above extraction process, which is step 1), the first acid adjustment precipitation (i.e., "adjusting the pH value of the filtrate to 1.0-2.0 with 2 mol / L hydrochloric acid solution, keeping warm at 80°C for 30 minutes, standing for 24 hours, and filtering" in the above extraction process, which is step 2), the second acid adjustment precipitation (i.e., "adding 8 times the amount of water to the precipitate, stirring, adjusting the pH value to 6.0-7.0 with 40% sodium hydroxide solution, adding an equal amount of ethanol, stirring to dissolve, filtering, adjusting the pH value of the filtrate to 2.0 with 2 mol / L hydrochloric acid solution, keeping warm at 80°C for 30 minutes, standing for 12 hours, and filtering" in the above extraction process, which is step 3) and the extract obtained at last (step 4) were tested for the residual amounts of methamidophos and omethoate, and the results are shown in Table 3 below. The obtained Scutellaria baicalensis extract was put into the preparation process of Shuanghuanglian eye drops.

[0225] Table 3 Residues of methamidophos and omethoate in each step of Scutellaria baicalensis extraction

[0226]

[0227] The preparation process of Shuanghuanglian eye drops includes: taking Scutellaria baicalensis extract, adding appropriate amount of water, heating and adjusting the pH value to 7.0 with 40% sodium hydroxide solution to dissolve, adding appropriate amount of the above-mentioned honeysuckle and forsythia extracts, adding water to 200 ml, adding 0.5% activated carbon, maintaining pH 7.0, heating to a slight boil for 15 minutes, cooling, filtering, adding water for injection to the full amount, sterilizing at 115°C for 30 minutes, refrigerating for 1 week, filtering with a microporous filter membrane, concentrating the filtrate, freeze-drying, packaging into 200 vials, each with 60 mg, and tightly sealing.

[0228] The contents of methamidophos and omethoate and the content of chlorogenic acid were tested in the decarbonization (step 5), sterilization (step 6), refrigeration (step 7) and freeze-drying (step 8) of the above preparation process. The results are shown in Table 4 below:

[0229] Table 4 Effects of methamidophos and omethoate residues in Scutellaria baicalensis extract on chlorogenic acid in the preparation process

[0230]

[0231] In the above Example 9, in order to study the effect of the residues of methamidophos and omethoate on the chlorogenic acid content of the preparation when methamidophos and omethoate were not completely removed during the extraction process of preparing the Scutellaria baicalensis extract, a Scutellaria baicalensis medicinal material containing a large amount of methamidophos and omethoate was selected. In this example, in the sterilization process (corresponding to step 6) of preparing the preparation, the residues of methamidophos and omethoate can be controlled to be undetectable, but in the decarbonization process (corresponding to step 5) of Example 9, the residues of methamidophos and omethoate still affect the content of chlorogenic acid.

[0232] The above example results prove that the methamidophos and omethoate residues in the scutellaria baicalensis medicinal material of Shuanghuanglian eye drops will be completely removed during the sterilization process of the preparation, but they can still affect the effective substance chlorogenic acid in the preparation before removal. Therefore, it is necessary to ensure that the methamidophos and omethoate content of scutellaria baicalensis are not detected before adding the honeysuckle extract, that is, in the extraction step 4 of scutellaria baicalensis. In order to avoid the situation of affecting the content of chlorogenic acid in the preparation, in a specific embodiment of the present invention, the content of methamidophos and omethoate in the scutellaria baicalensis medicinal material to be extracted is more strictly controlled to be undetectable.

[0233] Experimental Example 3 Effects of pesticide residues in Forsythia suspensa on chlorogenic acid

[0234] The extraction process of Forsythia suspensa is exactly the same as that of Honeysuckle. The process is implemented as follows: 500g of Forsythia suspensa is soaked in water for 30 minutes, decocted twice, each time for 1 hour, the decoction is combined and filtered, the filtrate is concentrated to a clear paste with a relative density of 1.20-1.25 (70°C), cooled to 40°C, ethanol is slowly added to make the alcohol content reach 75%, fully stirred, allowed to stand for 12 hours, the supernatant is filtered, the ethanol is recovered until there is no alcohol taste, water is added and allowed to stand for 12 hours, the supernatant is filtered, concentrated to a clear paste with a relative density of 1.10-1.15 (80°C), cooled to 40°C, ethanol is added to make the alcohol content reach 85%, allowed to stand for more than 12 hours, the supernatant is filtered, and the ethanol is recovered until there is no alcohol taste, and the extract is obtained.

[0235] In the above extraction process, the decoction is completed (i.e., "decoction twice, each time for 1 hour, and the combined decoction is filtered" in the above extraction. This is step 1), the concentration is completed (i.e., "the filtrate is concentrated to a clear paste with a relative density of 1.20-1.25 (70°C)" in the above extraction. This is step 2), and the 75% alcohol precipitation and concentration are completed (i.e., "cooling to 40°C, slowly adding ethanol to make the alcohol content reach 75%, fully stirring, standing for 12 hours, filtering the supernatant, and recovering ethanol until there is no alcohol taste" in the above extraction. This is step 3). After the extraction was completed (i.e., "add water and let stand for 12 hours, filter out the supernatant, and concentrate to a clear paste with a relative density of 1.10-1.15 (80°C)", which is step 4), and 85% alcohol precipitation and concentration was completed (i.e., "cool to 40°C, add ethanol to make the alcohol content reach 85%, let stand for more than 12 hours, filter out the supernatant, and recover the ethanol until there is no alcohol taste", which is step 5), the samples in each step were tested for the content of methyl parathion and oxydemeton-methyl pesticides, and the results are shown in Table 5 below. The obtained Forsythia suspensa extract was put into the preparation process of Shuanghuanglian eye drops.

[0236] Table 5 Residues of methamidophos and omethoate in each step of the extraction of Forsythia suspensa

[0237]

[0238] The above example results prove that when the content of methamidophos in 500g of Forsythia suspensa in Example 10 is 5.16μg and the content of oxydemeton-methyl is 7.79μg, that is, when the content of methamidophos in Forsythia suspensa is 10.32μg / kg and the content of oxydemeton-methyl is 15.58μg / kg, after step 1 of Forsythia suspensa extraction, methamidophos and oxydemeton-methyl still remain. When the content of methamidophos in 500g of Forsythia suspensa in Example 11 is 2.11μg and the content of oxydemeton-methyl is 3.23μg, that is, when the content of methamidophos in Forsythia suspensa is 4.22μg / kg and the content of oxydemeton-methyl is 6.46μg / kg, after step 1 of Forsythia suspensa extraction, methamidophos and oxydemeton-methyl have been completely removed. Therefore, when the residual amount of methamidophos in the forsythiae in Shuanghuanglian eye drops is controlled to be below 5 μg / kg, for example, further controlled to be below 4 μg / kg, and the residual amount of omethoate is controlled to be below 8 μg / kg, for example, further controlled to be below 6 μg / kg, methamidophos and omethoate have been completely removed after the forsythiae extraction step 1, and the forsythiae extract no longer contains pesticide residues. Therefore, it will not affect the active ingredient chlorogenic acid in honeysuckle in the preparation.

[0239] Experimental Example 4 Effect of supercritical pretreatment of honeysuckle, forsythia and scutellaria to remove pesticide residues on the active ingredients

[0240] The above experiments 1-3 can prove that any one of the three herbs, whether it is honeysuckle, forsythia or scutellaria, will affect the quality of Shuanghuanglian eye drops as long as it contains high residual methamidophos and omethoate. Therefore, one of the herbs is selected to use supercritical treatment technology to reduce the content of methamidophos and omethoate, and to examine whether it affects the content of the effective substance chlorogenic acid after extraction. This result can also represent the effect that can be obtained by using supercritical treatment technology for other herbs.

[0241] The three medicinal materials of honeysuckle, forsythia and scutellaria with high pesticide residue content were subjected to supercritical treatment using carbon dioxide supercritical treatment technology to remove methamidophos and oxydemeton-methyl. The contents of methamidophos and oxydemeton-methyl as well as chlorogenic acid were tested respectively, and extraction was carried out after passing the test.

[0242] Example 12: Honeysuckle medicinal material is treated with supercritical carbon dioxide. The process includes static extraction, dynamic extraction and two-stage analysis. The temperature of static extraction, dynamic extraction and two-stage analysis is 30°C, the static extraction pressure is 10MPa, and the extraction time is 20 minutes; the dynamic extraction pressure is 25MPa, and the extraction time is 5 hours; the first-level analysis pressure is 8MPa, and the second-level analysis pressure is 5MPa. The carbon dioxide flow rate is 1000L / h.

[0243] The extraction method of honeysuckle and the detection methods of chlorogenic acid, methamidophos and oxydemeton-methyl are the same as those in the example of Experiment 1-1. The following Table 6 respectively represents the chlorogenic acid content of honeysuckle without methamidophos and oxydemeton-methyl pesticide residues in each extraction step (Example 1'), the chlorogenic acid content of honeysuckle treated with supercritical carbon dioxide in each extraction step (Example 12), and the chlorogenic acid content of honeysuckle containing methamidophos and oxydemeton-methyl pesticide residues and not treated with supercritical carbon dioxide in each extraction step (Example 3).

[0244] Table 6 Effect of supercritical carbon dioxide treatment on chlorogenic acid content

[0245]

[0246] The above test proves that after the honeysuckle medicinal material is treated with supercritical carbon dioxide, the amount of methamidophos and oxydemeton-methyl pesticide residues can be effectively reduced, and there is no substantial impact on the effective substance chlorogenic acid contained in the honeysuckle medicinal material. After the medicinal material is extracted by supercritical treatment, the chlorogenic acid content is significantly better than that of the medicinal material that has not been treated with supercritical carbon dioxide. Therefore, the use of supercritical carbon dioxide treatment can effectively reduce pesticide residues and will not affect the effective substances in the medicinal material extraction process.

[0247] Experimental Example 5: Preparations were made by extracting controlled pesticide residues and processed medicinal materials to verify the effects of different treatments on the content of chlorogenic acid in eye drops

[0248] The honeysuckle herbal medicine with controlled methamidophos and omethoate content or the honeysuckle herbal medicine treated with methamidophos and omethoate by supercritical carbon dioxide treatment, and the herbal medicines of Forsythia suspensa and Scutellaria baicalensis were used to prepare Shuanghuanglian eye drops after extraction, and the chlorogenic acid content in the preparation was checked. The results are shown in Table 7 below:

[0249] Table 7 Chlorogenic acid content in preparations made from medicinal materials with different treatments

[0250]

[0251] The above test proves that when the content of methamidophos and oxydemeton-methyl in the medicinal materials is controlled, that is, when the content of methamidophos in the honeysuckle medicinal materials is controlled to be no more than 4μg / kg and the content of oxydemeton-methyl is controlled to be no more than 6μg / kg, the content of chlorogenic acid equivalent to that when neither methamidophos nor oxydemeton-methyl is detected can be obtained. At the same time, when the content of methamidophos in the honeysuckle medicinal materials is greater than 4μg / kg and the content of oxydemeton-methyl is greater than 6μg / kg, after supercritical treatment, the content of chlorogenic acid equivalent to that when neither methamidophos nor oxydemeton-methyl is detected can also be obtained. In addition, when the content of methamidophos in the honeysuckle medicinal materials is greater than 4μg / kg and the content of oxydemeton-methyl is greater than 6μg / kg, the content of chlorogenic acid is reduced.

[0252] It can be seen that by controlling the content of methyl parathion and oxydemeton-methyl in medicinal materials, the quality stability of Shuanghuanglian eye drops can be improved.

[0253] The above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, a person skilled in the art should understand that the specific implementation mode of the present invention can still be modified or some technical features can be replaced by equivalents without departing from the spirit of the technical solution of the present invention, which should be included in the scope of the technical solution for protection of the present invention.

Claims

1. A method for improving the quality stability of Shuanghuanglian eye drops, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, and the method comprises the following steps: 1) extracting honeysuckle, scutellaria baicalensis and forsythia suspensa to obtain corresponding medicinal material extracts for preparing Shuanghuanglian eye drops; 2) using the obtained medicinal material extract to prepare Shuanghuanglian eye drops; in, Step 1) includes: - Control the content of methamidophos in at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof to be no more than 5 μg / kg, and the content of omethoate to be no more than 8 μg / kg, so as to reduce the effects of methamidophos and omethoate on chlorogenic acid during the extraction process; - Extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops.

2. The method according to claim 1, wherein controlling the methamidophos content in the at least one medicinal material to be extracted to be no more than 5 μg / kg means controlling the methamidophos content to be no more than 4 μg / kg.

3. The method according to claim 1, wherein controlling the methamidophos content in the at least one medicinal material to be extracted to be no more than 5 μg / kg means controlling the methamidophos content to be undetectable.

4. The method according to claim 1, wherein controlling the omethoate content in the at least one medicinal material to be extracted to be no more than 8 μg / kg means controlling the omethoate content in the at least one medicinal material to be extracted to be no more than 6 μg / kg.

5. The method according to claim 1, wherein controlling the omethoate content in the at least one medicinal material to be extracted to be no more than 8 μg / kg means controlling the omethoate content to be undetectable.

6. The method according to claim 1, in, The content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps: - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted; - if the content of methamidophos in the at least one medicinal material to be extracted is detected to be no more than 5 μg / kg, and the content of omethoate in the at least one medicinal material to be extracted is detected to be no more than 8 μg / kg, then extraction is performed; If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 5 μg / kg and the content of oxydemeton-methyl is no more than 8 μg / kg, and then extraction is carried out.

7. The method according to claim 6, wherein detecting that the methamidophos content in the at least one medicinal material to be extracted is no more than 5 μg / kg means detecting that the methamidophos content is no more than 4 μg / kg.

8. The method according to claim 6, wherein detecting that the methamidophos content in the at least one medicinal material to be extracted is no more than 5 μg / kg means detecting that the methamidophos content is undetectable.

9. The method according to claim 6, wherein detecting that the omethoate content in the at least one medicinal material to be extracted is no more than 8 μg / kg means detecting that the omethoate content is no more than 6 μg / kg.

10. The method according to claim 6, wherein detecting that the omethoate content in the at least one medicinal material to be extracted is not greater than 8 μg / kg means detecting that the omethoate content is not detected.

11. The method according to claim 6, in, - if the content of methamidophos in the at least one medicinal material to be extracted is detected to be no more than 4 μg / kg, and the content of omethoate in the at least one medicinal material to be extracted is detected to be no more than 6 μg / kg, then extraction is performed; If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg and the content of oxydemeton-methyl is no more than 6 μg / kg, and then extraction is carried out.

12. The method according to claim 11, in, If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first performed until the content of methyl parathion and the content of oxydemeton-methyl are undetectable, and then extraction is performed.

13. The method according to claim 6, in, The pesticide residue removal treatment is carried out by supercritical carbon dioxide treatment.

14. The method according to any one of claims 1 to 13, wherein the at least one medicinal material to be extracted comprises honeysuckle alone, forsythia suspensa alone, scutellaria baicalensis alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, a combination of forsythia suspensa and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

15. The method according to any one of claims 1 to 13, wherein the at least one medicinal material to be extracted is honeysuckle alone, forsythia suspensa alone, scutellaria baicalensis alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, a combination of forsythia suspensa and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

16. The method according to any one of claims 1 to 13, wherein the at least one medicinal material to be extracted comprises honeysuckle alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

17. The method according to any one of claims 1 to 13, wherein the at least one medicinal material to be extracted is honeysuckle alone, a combination of honeysuckle and Forsythia suspensa, a combination of honeysuckle and Scutellaria baicalensis, or a combination of honeysuckle, Forsythia suspensa and Scutellaria baicalensis.

18. The method according to any one of claims 1 to 13, wherein the at least one medicinal material to be extracted comprises Flos Lonicerae alone, and optionally, Fructus Forsythiae alone and / or Radix Scutellariae alone.

19. The method according to any one of claims 1 to 13, wherein the at least one medicinal material to be extracted is Flos Lonicerae alone, and optionally, Fructus Forsythiae alone and / or Radix Scutellariae alone.

20. The method according to any one of claims 1 to 13, wherein the at least one medicinal material to be extracted comprises honeysuckle, include: - Control the content of methyl parathion in the honeysuckle medicinal material to be extracted to be no more than 5 μg / kg, and control the content of omethoate in the honeysuckle medicinal material to be extracted to be no more than 8 μg / kg; - Extracting the honeysuckle medicinal material to be extracted to obtain the honeysuckle extract for preparing Shuanghuanglian eye drops. The method according to claim 20 , wherein the at least one medicinal material to be extracted comprises honeysuckle alone.

22. The method according to claim 20, wherein controlling the content of methamidophos in the honeysuckle medicinal material to be extracted to be no more than 5 μg / kg means controlling the content of methamidophos in the honeysuckle medicinal material to be extracted to be no more than 4 μg / kg.

23. The method according to claim 20, wherein controlling the content of methyl parathion in the honeysuckle medicinal material to be extracted to be no more than 5 μg / kg means controlling the content of methyl parathion in the honeysuckle medicinal material to be extracted to be undetectable.

24. The method according to claim 20, wherein controlling the content of omethoate in the honeysuckle medicinal material to be extracted to be no more than 8 μg / kg means controlling the content of omethoate in the honeysuckle medicinal material to be extracted to be no more than 6 μg / kg.

25. The method according to claim 20, wherein controlling the content of omethoate in the honeysuckle medicinal material to be extracted to be no more than 8 μg / kg means controlling the content of omethoate in the honeysuckle medicinal material to be extracted to be undetectable.

26. The method of claim 20, wherein (i) the at least one medicinal material to be extracted further comprises Forsythia suspensa, and the method further comprises include: - Control the content of methamidophos in the forsythia suspensa to be extracted to be no more than 5 μg / kg, and control the content of omethoate in the forsythia suspensa to be extracted to be no more than 8 μg / kg; - extracting the Forsythia suspensa medicinal material to be extracted or extracting the Forsythia suspensa medicinal material to be extracted and the Honeysuckle medicinal material to be extracted, so as to obtain an extract for preparing Shuanghuanglian eye drops; and / or (ii) the at least one medicinal material to be extracted further comprises Scutellaria baicalensis, and the method further comprises: -Control the content of methamidophos in the Radix Scutellariae to be extracted to be undetectable, and the content of omethoate to be undetectable; - Extracting the Radix Scutellariae Radix to be extracted to obtain the Radix Scutellariae Radix extract for preparing Shuanghuanglian eye drops.

27. The method according to claim 26, wherein the at least one medicinal material to be extracted comprises Forsythia suspensa alone.

28. The method according to claim 26, wherein controlling the content of methamidophos in the Forsythia suspensa to be extracted to be no more than 5 μg / kg means controlling the content of methamidophos in the Forsythia suspensa to be extracted to be no more than 4 μg / kg.

29. The method according to claim 26, wherein controlling the content of methamidophos in the Forsythia suspensa to be extracted to be no more than 5 μg / kg means controlling the content of methamidophos in the Forsythia suspensa to be extracted to be undetectable.

30. The method according to claim 26, wherein controlling the content of omethoate in the Forsythia suspensa to be extracted to be no more than 8 μg / kg means controlling the content of omethoate in the Forsythia suspensa to be extracted to be no more than 6 μg / kg.

31. The method according to claim 26, wherein controlling the content of omethoate in the Forsythia suspensa to be extracted to be no more than 8 μg / kg means controlling the content of omethoate in the Forsythia suspensa to be extracted to be undetectable.

32. The method according to claim 26, wherein the at least one medicinal material to be extracted comprises Scutellaria baicalensis alone.

33. A method for extracting an extract for preparing Shuanghuanglian eye drops from medicinal materials, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa. include: 1) providing at least one medicinal material to be extracted selected from honeysuckle, scutellaria, forsythia or any combination thereof; 2) controlling the content of methamidophos in the at least one medicinal material to be extracted to be no more than 5 μg / kg, and controlling the content of omethoate in the at least one medicinal material to be extracted to be no more than 8 μg / kg, so as to reduce the effects of methamidophos and omethoate on chlorogenic acid during the extraction process; 3) extracting the at least one medicinal material to be extracted to obtain a medicinal material extract for preparing Shuanghuanglian eye drops.

34. The method according to claim 33, wherein controlling the methamidophos content in the at least one medicinal material to be extracted to be no more than 5 μg / kg means controlling the methamidophos content to be no more than 4 μg / kg.

35. The method according to claim 33, wherein controlling the methamidophos content in the at least one medicinal material to be extracted to be no more than 5 μg / kg means controlling the methamidophos content to be undetectable.

36. The method according to claim 33, wherein controlling the omethoate content in the at least one medicinal material to be extracted to be no more than 8 μg / kg means controlling the omethoate content in the at least one medicinal material to be extracted to be no more than 6 μg / kg.

37. The method according to claim 33, wherein controlling the omethoate content in the at least one medicinal material to be extracted to be no more than 8 μg / kg means controlling the omethoate content to be undetectable.

38. The method according to claim 33, wherein the content of methamidophos and omethoate in the at least one medicinal material to be extracted is controlled by the following steps: - detecting the content of methamidophos and omethoate in the at least one medicinal material to be extracted; - if the content of methamidophos in the at least one medicinal material to be extracted is detected to be no more than 5 μg / kg, and the content of omethoate in the at least one medicinal material to be extracted is detected to be no more than 8 μg / kg, then extraction is performed; If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 5 μg / kg and / or the content of oxydemeton-methyl is greater than 8 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 5 μg / kg and the content of oxydemeton-methyl is no more than 8 μg / kg, and then extraction is carried out.

39. The method according to claim 38, wherein detecting that the methamidophos content in the at least one medicinal material to be extracted is no more than 5 μg / kg means detecting that the methamidophos content is no more than 4 μg / kg.

40. The method according to claim 38, wherein detecting that the methamidophos content in the at least one medicinal material to be extracted is no more than 5 μg / kg means detecting that the methamidophos content is undetectable.

41. The method according to claim 38, wherein detecting that the omethoate content in the at least one medicinal material to be extracted is no more than 8 μg / kg means detecting that the omethoate content is no more than 6 μg / kg.

42. The method according to claim 38, wherein detecting that the omethoate content in the at least one medicinal material to be extracted is no more than 8 μg / kg means detecting that the omethoate content is not detected.

43. The method of claim 38, wherein - if the content of methamidophos in the at least one medicinal material to be extracted is detected to be no more than 4 μg / kg, and the content of omethoate in the at least one medicinal material to be extracted is detected to be no more than 6 μg / kg, then extraction is performed; If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first carried out until the content of methyl parathion is no more than 4 μg / kg and the content of oxydemeton-methyl is no more than 6 μg / kg, and then extraction is carried out.

44. The method according to claim 43, in, If it is detected that the content of methyl parathion in at least one of the medicinal materials to be extracted is greater than 4 μg / kg and / or the content of oxydemeton-methyl is greater than 6 μg / kg, pesticide residue removal treatment is first performed until the content of methyl parathion and the content of oxydemeton-methyl are undetectable, and then extraction is performed.

45. The method according to claim 38, wherein the pesticide residue removal treatment is carried out by supercritical carbon dioxide treatment.

46. ​​The method according to any one of claims 33-45, wherein the at least one medicinal material to be extracted comprises honeysuckle alone, forsythia suspensa alone, scutellaria baicalensis alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, a combination of forsythia suspensa and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

47. The method according to any one of claims 33 to 45, wherein the at least one medicinal material to be extracted is honeysuckle alone, forsythia suspensa alone, scutellaria baicalensis alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, a combination of forsythia suspensa and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

48. The method according to any one of claims 33 to 45, wherein the at least one medicinal material to be extracted comprises honeysuckle alone, a combination of honeysuckle and forsythia suspensa, a combination of honeysuckle and scutellaria baicalensis, or a combination of honeysuckle, forsythia suspensa and scutellaria baicalensis.

49. The method according to any one of claims 33 to 45, wherein the at least one medicinal material to be extracted is honeysuckle alone, a combination of honeysuckle and Forsythia suspensa, a combination of honeysuckle and Scutellaria baicalensis, or a combination of honeysuckle, Forsythia suspensa and Scutellaria baicalensis.

50. The method according to any one of claims 33 to 45, wherein the at least one medicinal material to be extracted comprises Flos Lonicerae alone, and optionally, Fructus Forsythiae alone and / or Radix Scutellariae alone.

51. The method according to any one of claims 33 to 45, wherein the at least one medicinal material to be extracted is Flos Lonicerae alone, and optionally, Fructus Forsythiae alone and / or Radix Scutellariae alone.

52. A method for preparing Shuanghuanglian eye drops, wherein the Shuanghuanglian eye drops are prepared from extracts of honeysuckle, scutellaria baicalensis and forsythia suspensa, comprising the following steps: 1) extracting honeysuckle, scutellaria baicalensis and forsythia suspensa to obtain corresponding medicinal material extracts; 2) using the obtained medicinal material extract to prepare Shuanghuanglian eye drops; Wherein at least one selected from the following: honeysuckle extract, scutellaria baicalensis extract, forsythia suspensa extract, or a combination thereof is prepared by the method according to any one of claims 1 to 51.

53. The method according to claim 52, wherein the at least one is selected from the group consisting of a honeysuckle extract, a forsythia extract, a scutellaria extract, an extract of a combination of honeysuckle and forsythia, an extract of a combination of honeysuckle and scutellaria, an extract of a combination of forsythia and scutellaria, and / or an extract of a combination of honeysuckle, forsythia and scutellaria.

54. The method according to claim 52, wherein the at least one extract is selected from the group consisting of a honeysuckle extract, an extract of a combination of honeysuckle and Forsythia suspensa, an extract of a combination of honeysuckle and Scutellaria baicalensis, and / or an extract of a combination of honeysuckle, Forsythia suspensa and Scutellaria baicalensis.

55. The method according to claim 52, wherein the at least one extract is selected from the group consisting of honeysuckle extract, and / or a combination of honeysuckle and forsythia.

56. A Shuanghuanglian eye drops prepared by the method described in any one of claims 52-55.